Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule...
33 insider purchases on record · latest filing 2020-01-02.
Insiders have also filed 1,358 sale transactions at CYTK.